Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02603445
Title Study of Safety and Efficacy of BCL201 and Idelalisib in Patients With FL and MCL
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

mantle cell lymphoma

follicular lymphoma

Therapies

BCL201 + Idelalisib

Age Groups: adult | senior
Covered Countries USA | FRA | DEU | AUT


No variant requirements are available.